decisionhealth Newsletters, Coder Pink Sheets - 2010 Issue 9 (September)
Mind your modifiers: Follow CMS’s rules for modifier JW
Subscribe or sign in to view the full article.
Article Overview
This article reviews CMS guidance on modifier JW in the context of Medicare drug and biological billing. It is aimed at coders, billers, and revenue cycle staff who handle claims involving discarded portions of single-use drugs, and it summarizes the CMS update, related claim-line reporting, and limitations mentioned by the source.
Why This Topic Matters
Correct handling of discarded drug amounts affects Medicare payment accuracy and claim compliance. Readers looking for CMS billing updates or guidance on drug wastage reporting will want the article for its summary of the modifier JW rule changes and associated restrictions.
What You Will Learn
- The CMS context for updated drug billing guidance
- How the article frames reporting discarded or unused drug amounts on claims
- The general limitations noted for certain drug billing situations
- Where the article points readers for the official CMS transmittal
Who Should Read This
- Medical coders
- Billing specialists
- Revenue cycle staff
- Compliance professionals
- Physician practice administrators
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com